MultiCell hires CRO to for MCT125 phase IIb MS fatigue trial

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

MultiCell hires CRO to for MCT125 phase IIb MS fatigue trial

Postby MSUK » Sun Jul 11, 2010 6:05 am

Image

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has retained Clinical Development & Support Services, Ltd. (CDSS) of Cheshire, England to manage its planned Phase IIb clinical trial in the United Kingdom for MCT-125.

MCT-125 is the company's lead drug candidate for treatment of primary multiple sclerosis-related fatigue (PMSF).

In an earlier Phase IIa study, MCT-125 was tested on 138 patients suffering from PMSF. MCT-125 was shown to be effective within 4 weeks of administration, was active across all multiple sclerosis (MS) disease severity assessment scales, and on patients regardless of MS disease sub-type (primary progressive, secondary progressive and relapsing-remitting).... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2354
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2211
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service